The Road Ahead: Advancing Antifungal Vaccines and Addressing Fungal Infections in the Post-COVID World-Reference-Cited by-同舟云学术

The Road Ahead: Advancing Antifungal Vaccines and Addressing Fungal Infections in the Post-COVID World

Published:2024-09-10 Issue: Volume: Page:
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Gong Xiaolong¹,Wani Mohmmad Younus²^ORCID,Al-Bogami Abdullah Saad²,Ahmad Aijaz¹³^ORCID,Robinson Keven³,Khan Amber⁴

Affiliation:

1. Clinical Microbiology and Infectious Diseases, School of Pathology, Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa

2. Department of Chemistry, College of Science, University of Jeddah, 21589, Jeddah, Saudi Arabia

3. Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, United States

4. Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States

Funder

National Health Laboratory Service

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.4c00245

Reference192 articles.

1. Global incidence and mortality of severe fungal disease

2. Immunization with the Candida albicans Membrane Fraction and in Combination with Fluconazole Protects against Systemic Fungal Infections

3. Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis

4. Design of a multi-epitope vaccine against the pathogenic fungi Candida tropicalis using an in silico approach

5. Gaffi. Country Fungal Disease Burdens: Gaffi; 2024 [Available from: https://gaffi.org/media/country-fungal-disease-burdens/].